Quantum
Home > Boards > US Listed > Medical - Drugs >

Merck & Co. Inc. (MRK)

MRK RSS Feed
Add MRK Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 11/14/2018 8:25:55 AM - Followers: 39 - Board type: Free - Posts Today: 0
Quantum
MRK
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MRK News: Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Compared to Chemotherapy in Patients with A... 11/14/2018 06:45:00 AM
MRK News: Merck Begins Rolling Submission of Licensure Application for V920 (rVSV?G-ZEBOV-GP) to U.S. Food and Drug Administration 11/13/2018 04:35:00 PM
MRK News: FDA Accepts Regulatory Submission for LYNPARZA® (olaparib) Maintenance Therapy in Newly-Diagnosed, BRCA-Mutated Advanced Ova... 11/12/2018 06:55:00 AM
MRK News: FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have ... 11/09/2018 04:21:00 PM
MRK News: New Data from Investigational Study of LENVIMA® (lenvatinib) & KEYTRUDA® (pembrolizumab) Combination in Three Different Tum... 11/09/2018 06:45:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#392  Sticky Note MRK 3Q18 items… DewDiligence 10/25/18 09:18:16 AM
#406   KEYNOTE-181 in second-line esophageal cancer hits primary OS DewDiligence 11/14/18 08:25:55 AM
#405   FDA approves Keytruda monotherapy for second-line HCC: DewDiligence 11/09/18 06:58:30 PM
#396   $MRK has no reason to partner with a RiverNorth0x 10/28/18 12:04:19 PM
#395   $MRK - $UNVC CBD JV speculation running rampant mikeyt1818 10/27/18 11:20:27 PM
#394   MRK 3Q18 CC transcript: DewDiligence 10/26/18 10:54:59 AM
#393   MRK 2018 non-GAAP EPS guidance raised to $4.30-4.36 DewDiligence 10/25/18 09:34:25 AM
#392   MRK 3Q18 items… DewDiligence 10/25/18 09:18:16 AM
#391   CEO of UNVC posting to article about CEO wrenchman 10/25/18 04:16:29 AM
#390   The dots are connecting UNVC/MERCK Killer Whale 10/24/18 10:55:19 PM
#389   Another viewpoint on the $MRK / $UNVC partnership: Almost A Myth 10/24/18 09:45:35 PM
#388   Great news! The “green wave” is a once Real Bruce Wayne 10/24/18 09:28:20 PM
#387   Great stuff. Dr David Dalton has been dealing mikeyt1818 10/24/18 09:27:56 PM
#386   Serious speculation regarding $MRK - $UNVC partnership. Almost A Myth 10/24/18 09:14:22 PM
#385   It will be interesting to see the early jondoeuk 10/17/18 05:16:39 PM
#384   MRK reveals ESMO lineup: DewDiligence 10/09/18 11:36:19 AM
#383   Keytruda-monotherapy PDUFA in first-line NSCLC=1/11/19 (with priority review): DewDiligence 09/12/18 11:23:45 AM
#382   FDA approves Pifeltro and Delstrigo for HIV: #msg-143282228. DewDiligence 08/30/18 05:28:01 PM
#381   Keytruda/chemo in 1L-NSCLC converted to full FDA approval DewDiligence 08/20/18 04:31:23 PM
#380   Any thoughts if mrk can get to 75 harry crumb 08/16/18 09:54:39 PM
#379   FDA approves Lenvima in HCC: #msg-142966722. DewDiligence 08/16/18 04:50:45 PM
#377   MRK 2Q18 CC transcript: DewDiligence 07/28/18 12:27:22 PM
#376   MRK 2Q18 results: DewDiligence 07/27/18 08:32:01 AM
#375   Selling MRK covered calls is a better than fishhunter 07/19/18 10:16:09 AM
#373   Keytruda-monotherapy PDUFA in second-line HCC is 11/9/18 (with DewDiligence 07/11/18 11:26:59 AM
#372   Keytruda-monotherapy PDUFA in adjuvant melanoma is 2/16/19: #msg-141775785. DewDiligence 06/25/18 11:53:53 AM
#371   LA TIMES re Merck and Keytruda: north40000 06/21/18 05:31:40 PM
#370   FDA approves Ketruda monotherapy in second-line cervical cancer DewDiligence 06/12/18 03:19:28 PM
#369   Musings on MRK’s valuation: #msg-141323511. DewDiligence 06/05/18 06:51:19 PM
#368   MRK ASCO-CC slides: DewDiligence 06/04/18 07:45:14 PM
#367   MRK reveals OS hazard ratios in KEYNOTE-042: #msg-141266968. DewDiligence 06/03/18 07:05:07 PM
#366   MRK ASCO lineup: DewDiligence 05/17/18 10:44:25 AM
#364   MRK 1Q18 results: DewDiligence 05/01/18 09:57:21 AM
#363   BMY Bulls are throwing in the towel and chickpea598 04/23/18 08:53:15 PM
#362   Double upgrade on Lung Cancer drug! Buy! Buy! Buy! Paulsatsac 04/23/18 01:44:51 PM
#361   good to see, I agree. I didnt see dr_lowenstein 04/16/18 10:13:50 PM
#360   Merck regaining market confidence at AACR. NIce to chickpea598 04/16/18 08:18:04 PM
#359   MRK AACR-webcast slides: DewDiligence 04/16/18 08:11:05 PM
#358   OS HR=0.49 in KEYNOTE-189 overall trial: #msg-140072007. DewDiligence 04/16/18 11:32:57 AM
#357   MRK +6%; BMY -1% on Keytruda KEYNOTE-042 results: #msg-139894079. DewDiligence 04/09/18 12:01:58 PM
#356   INCY/MRK’s PR on phase-3 failure of Epacadostat as DewDiligence 04/06/18 09:44:44 AM
#355   MRK, Eisai ink global collaboration for Lenvima: #msg-139112383. DewDiligence 03/07/18 05:58:47 PM
#354   MRK’s PR on VLA.AX acquisition: DewDiligence 02/21/18 08:14:57 AM
#353   No updates of consequence to investors will be DewDiligence 02/16/18 02:44:10 AM
#352   How you you feel about this. Any more pennystockaholic 02/15/18 11:28:22 PM
#351   Verubecestat prodromal phase-3 stopped for futility: #msg-138524864. DewDiligence 02/13/18 07:23:09 PM
#349   MRK is driving up the DJIA past 26,000 crudeoil24 01/16/18 10:24:19 AM
#348   Gangbusters > solid FDA news: Merck's KEYTRUDA(R) (pembrolizumab) crudeoil24 01/16/18 10:09:36 AM
#347   Keytruda hits on OS/PFS in KEYNOTE-189: #msg-137706298. DewDiligence 01/16/18 09:31:53 AM
#346   Keytruda trial in second-line gastric cancer does not DewDiligence 12/14/17 06:14:19 PM
#345   Has moved above its one year target, but r clarke 12/06/17 04:41:33 PM
PostSubject